1. Home
  2. APGE vs RLX Comparison

APGE vs RLX Comparison

Compare APGE & RLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APGE
  • RLX
  • Stock Information
  • Founded
  • APGE 2022
  • RLX 2018
  • Country
  • APGE United States
  • RLX China
  • Employees
  • APGE N/A
  • RLX N/A
  • Industry
  • APGE Biotechnology: Biological Products (No Diagnostic Substances)
  • RLX Medicinal Chemicals and Botanical Products
  • Sector
  • APGE Health Care
  • RLX Health Care
  • Exchange
  • APGE Nasdaq
  • RLX Nasdaq
  • Market Cap
  • APGE 2.4B
  • RLX 2.8B
  • IPO Year
  • APGE 2023
  • RLX 2021
  • Fundamental
  • Price
  • APGE $66.64
  • RLX $2.45
  • Analyst Decision
  • APGE Strong Buy
  • RLX Hold
  • Analyst Count
  • APGE 9
  • RLX 1
  • Target Price
  • APGE $97.33
  • RLX $2.25
  • AVG Volume (30 Days)
  • APGE 730.3K
  • RLX 2.1M
  • Earning Date
  • APGE 11-10-2025
  • RLX 11-14-2025
  • Dividend Yield
  • APGE N/A
  • RLX 4.08%
  • EPS Growth
  • APGE N/A
  • RLX 19.33
  • EPS
  • APGE N/A
  • RLX 0.08
  • Revenue
  • APGE N/A
  • RLX $459,694,770.00
  • Revenue This Year
  • APGE N/A
  • RLX $59.70
  • Revenue Next Year
  • APGE N/A
  • RLX $27.15
  • P/E Ratio
  • APGE N/A
  • RLX $29.54
  • Revenue Growth
  • APGE N/A
  • RLX 51.58
  • 52 Week Low
  • APGE $26.20
  • RLX $1.66
  • 52 Week High
  • APGE $67.66
  • RLX $2.84
  • Technical
  • Relative Strength Index (RSI)
  • APGE 73.22
  • RLX 54.28
  • Support Level
  • APGE $61.81
  • RLX $2.42
  • Resistance Level
  • APGE $67.66
  • RLX $2.59
  • Average True Range (ATR)
  • APGE 3.73
  • RLX 0.09
  • MACD
  • APGE 0.19
  • RLX 0.02
  • Stochastic Oscillator
  • APGE 91.78
  • RLX 63.89

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About RLX RLX Technology Inc. each representing the right to receive one (1) ordinary share

RLX Technology Inc is engaged in the manufacturing of e-vapor products for adult smokers. It has an integrated offline distribution and "Branded store plus" retail model tailored to China's e-vapor market.

Share on Social Networks: